isirv

| Print |

Return to Menu

Our thanks to the main supporters of RSV2022



	We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Visit the website.

	At GSK we unite science, technology and talent to get ahead of disease together We prevent and treat disease with vaccines, specialty and general medicines. We are one of the world’s largest vaccines companies, with the broadest portfolio of vaccines on the market and a strong pipeline of vaccines in development. We supply more than 20 vaccines to more than 160 countries to help protect people from a range of diseases throughout their lives. Our vaccines help prevent illnesses such as hepatitis A and B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, pneumococcal disease, influenza, shingles and meningitis. Our pipeline is underpinned by a broad portfolio of technology platforms, including mRNA, that will ensure we continue to deliver highly innovative vaccines. For further information, please visit the website.

	AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit the website and follow the Company on Twitter @AstraZeneca.